Reference
Dong C, et al. Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment. Frontiers in Oncology 12: 17 Oct 2022. Available from: URL: http://doi.org/10.3389/fonc.2022.992596
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1940, 318 (2023). https://doi.org/10.1007/s40278-023-32176-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-32176-y